SE8301038D0 - Tiopyranopyrimidinforeningar och syraadditionssalter derav - Google Patents

Tiopyranopyrimidinforeningar och syraadditionssalter derav

Info

Publication number
SE8301038D0
SE8301038D0 SE8301038A SE8301038A SE8301038D0 SE 8301038 D0 SE8301038 D0 SE 8301038D0 SE 8301038 A SE8301038 A SE 8301038A SE 8301038 A SE8301038 A SE 8301038A SE 8301038 D0 SE8301038 D0 SE 8301038D0
Authority
SE
Sweden
Prior art keywords
compounds
acid addition
addition salts
activity
tiopyranopyrimide
Prior art date
Application number
SE8301038A
Other languages
English (en)
Other versions
SE451135B (sv
SE8301038L (sv
Inventor
S Ohno
K Mizukoshi
O Komatsu
H Yamamoto
Y Kunou
Original Assignee
Maruko Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP57029594A external-priority patent/JPS58146586A/ja
Priority claimed from JP58015097A external-priority patent/JPS59141583A/ja
Application filed by Maruko Pharmaceutical Co filed Critical Maruko Pharmaceutical Co
Publication of SE8301038D0 publication Critical patent/SE8301038D0/sv
Publication of SE8301038L publication Critical patent/SE8301038L/sv
Publication of SE451135B publication Critical patent/SE451135B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SE8301038A 1982-02-25 1983-02-24 Tiopyranopyrimidinforeningar och syraadditionssalter derav SE451135B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP57029594A JPS58146586A (ja) 1982-02-25 1982-02-25 チオピラノピリミジン誘導体およびその酸付加塩
JP58015097A JPS59141583A (ja) 1983-02-01 1983-02-01 チオピラノピリミジン誘導体およびその酸付加塩

Publications (3)

Publication Number Publication Date
SE8301038D0 true SE8301038D0 (sv) 1983-02-24
SE8301038L SE8301038L (sv) 1983-08-26
SE451135B SE451135B (sv) 1987-09-07

Family

ID=26351189

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8301038A SE451135B (sv) 1982-02-25 1983-02-24 Tiopyranopyrimidinforeningar och syraadditionssalter derav

Country Status (12)

Country Link
US (1) US4435566A (sv)
KR (1) KR840003638A (sv)
CA (1) CA1217186A (sv)
CH (1) CH651305A5 (sv)
DE (1) DE3306485A1 (sv)
ES (2) ES520075A0 (sv)
FR (1) FR2522000B1 (sv)
GB (1) GB2119368B (sv)
HU (1) HU189666B (sv)
IT (1) IT1212855B (sv)
NL (1) NL8300656A (sv)
SE (1) SE451135B (sv)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0224722B1 (en) * 1985-11-04 1993-01-07 Merck & Co. Inc. The use of 6H-7,8-Dihydrothiapyrano[3,2-d]pyrimidines for the manufacture of medicaments for use as hypoglycemic agents or as weight reducers for obese patients
US4978667A (en) * 1986-12-15 1990-12-18 Merck & Co., Inc. Substituted 6H-7,8-dihydrothiapyrano(3,2-d)-pyrimidines as hypoglycemic agents
US4889856A (en) * 1987-08-31 1989-12-26 Merck & Co., Inc. 7,8-dihydro-4-(1-pierazinyl)-6H-thiopyrano-[3,2-d] pyrimidines as β-blockers
US4871739A (en) * 1987-01-21 1989-10-03 Merck & Co., Inc. Substituted 6H-7,8-dihydrothiapyrano(3,2-D)-pyrimidines as hyopglycemic agents
US5057517A (en) * 1987-07-20 1991-10-15 Merck & Co., Inc. Piperazinyl derivatives of purines and isosteres thereof as hypoglycemic agents
US4994464A (en) * 1987-08-31 1991-02-19 Merck & Co., Inc. Piperazinylpyrimidines as β-adrenergic receptor blockers
EP0335979A4 (en) * 1987-09-16 1992-02-26 Taiho Pharmaceutical Company, Limited Thienopyrimidine derivatives
US5869486A (en) * 1995-02-24 1999-02-09 Ono Pharmaceutical Co., Ltd. Fused pyrimidines and pyriazines as pharmaceutical compounds
US6022893A (en) * 1995-08-08 2000-02-08 Ono Pharmaceutical Co., Ltd. Hydroxamic acid derivatives

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB951432A (en) * 1959-03-17 1964-03-04 Wellcome Found Pyrimidine derivatives and the manufacture thereof
DE1470336A1 (de) 1962-07-04 1969-03-20 Thomae Gmbh Dr K Neue Dihydrothieno-[3,4-d]-pyrimidine und Verfahren zu ihrer Herstellung
DE1251765B (de) * 1963-07-23 1967-10-12 Dr Karl Thomae Gesellschaft mit beschrankter Haftung Biberach/Riß Verfahren zur Herstellung von neuen 5H - Dihydrothiopyrano [4 3 d] pynmidinen

Also Published As

Publication number Publication date
US4435566A (en) 1984-03-06
IT8347764A0 (it) 1983-02-23
SE451135B (sv) 1987-09-07
ES538649A0 (es) 1986-02-16
GB2119368A (en) 1983-11-16
KR840003638A (ko) 1984-09-15
GB2119368B (en) 1985-10-16
IT1212855B (it) 1989-11-30
HU189666B (en) 1986-07-28
FR2522000A1 (fr) 1983-08-26
ES8504810A1 (es) 1985-05-16
NL8300656A (nl) 1983-09-16
CH651305A5 (de) 1985-09-13
ES520075A0 (es) 1985-05-16
FR2522000B1 (fr) 1986-11-07
DE3306485A1 (de) 1983-09-08
GB8305175D0 (en) 1983-03-30
ES8604597A1 (es) 1986-02-16
SE8301038L (sv) 1983-08-26
CA1217186A (en) 1987-01-27

Similar Documents

Publication Publication Date Title
NO165838C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte trans-1,2-diamino-cykloheksylamidforbindelser.
NO166639C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte, basiske 2-aminotetraliner.
NO164835C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyril-derivater.
NO160521C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 13alfa- alkylgonaner.
NO871879D0 (no) Fremgangsmaate for fremstilling av nye, terapeutisk aktive heterocykliske forbindelser.
NO880182L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,2-dihydro-3h-indazol-3-on-derivater.
NO902411D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-hydroksy-n-propylaminer.
NO166362C (no) Analogifremgangsmaate for fremstilling av nye terapeutisk aktive polyaminderivater.
IT8322855A0 (it) Composizione farmaceutica per la cura delle arteriopatie periferiche.
NO166080C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5,6,8-trifluorkinoliner.
NO155490C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktivt 4-(1"-hydroksy-2"-(n-imidazolyl)etyl)bibenzyl.
NO164168C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 1,7,4-triazolforbindelser.
NO814424L (no) Fremgangsmaate for fremstilling av terapeutisk virksomme 5,5`-azobis-salisylsyreforbindelser.
NO883122D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive arylamid-derivater.
SE8301038L (sv) Tiopyranopyrimidinforeningar och syraadditionssalter derav
NO883485L (no) Fremgangsmaate for fremstilling av terapeutisk aktive piperidinyl-isokinolinforbindelser.
IT8005106A0 (it) Composti per il trattamento del glaucoma.
NO880667L (no) Fremgangsmaate for fremstilling av terapeutisk aktive arylpiperazinyl-alkylen-fenyl-heterocykliske forbindelser.
SE8301004L (sv) Pyridinforeningar
NO161800C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-(2-aryl-2-halo-1-etenyl)-1h-azoler.
NO881768L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksaner.
DE69023459T2 (de) Behandlung von pulmonarer Disfunktion mit 15-Keto-prostaglandin-Derivaten.
IT8123052A0 (it) Procedimento per la preparazione di trattamento di pozzi.
NO865148D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive, substituerte benzamider.
NO811360L (no) Fremgangsmaate for fremstilling av terapeutisk aktivt hydratisert picotamid.

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8301038-9

Effective date: 19920904

Format of ref document f/p: F